metoclopramide has been researched along with Kidney Diseases in 11 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Heptaplatin is a newly developed platinum derivative which has been reported to be less toxic than cisplatin." | 2.70 | Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer. ( Ahn, JH; Bahng, H; Chang, HM; Kang, WC; Kang, YK; Kim, TW; Kim, WK; Lee, JS; Park, JS, 2002) |
| " The effects of intravenous metoclopramide on baseline values and dopamine dose-response curves for renal haemodynamics and natriuresis were investigated in healthy volunteers and patients with renal disease." | 2.66 | Effect of metoclopramide on dopamine-induced changes in renal function in healthy controls and in patients with renal disease. ( Donker, AJ; Meijer, S; Reitsma, WD; Smit, AJ; Wesseling, H, 1988) |
| "Metoclopramide kinetics were examined in 24 adult patients with diminished renal function and in eight healthy subjects with normal renal function." | 1.27 | Metoclopramide kinetics in patients with impaired renal function and clearance by hemodialysis. ( Collins, CB; Crowe, JT; Heironimus, JD; Lehmann, CR; Melikian, AP; O'Neil, TJ; Pierson, WP; Wright, GJ, 1985) |
| "Metoclopramide has gained acceptance as an effective drug for the control of nausea and vomiting in cancer patients receiving cisplatin chemotherapy." | 1.27 | Lack of effect of metoclopramide on cisplatin-induced nephrotoxicity in rats. ( Buyan, RD; Perkins, WE; Schroeder, RL, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (72.73) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, JH | 1 |
| Kang, YK | 1 |
| Kim, TW | 1 |
| Bahng, H | 1 |
| Chang, HM | 1 |
| Kang, WC | 1 |
| Kim, WK | 1 |
| Lee, JS | 1 |
| Park, JS | 1 |
| Imoto, R | 1 |
| Tam, YK | 1 |
| Axelson, JE | 1 |
| McErlane, B | 1 |
| Kapil, RP | 1 |
| Riggs, KW | 1 |
| Ongley, R | 1 |
| Price, JD | 1 |
| Martín Carrasco, C | 1 |
| Rodríguez Vázquez, M | 1 |
| Palacios Garciá, R | 1 |
| St Peter, JV | 1 |
| Brady, ME | 1 |
| Foote, EF | 1 |
| Dandekar, KA | 1 |
| Smaldone, L | 1 |
| Pykkonen, JL | 1 |
| Keane, WF | 1 |
| Halstenson, CE | 1 |
| Smit, AJ | 1 |
| Meijer, S | 1 |
| Wesseling, H | 1 |
| Donker, AJ | 1 |
| Reitsma, WD | 1 |
| Sowers, JR | 1 |
| Beck, FW | 1 |
| Waters, BK | 1 |
| Barrett, JD | 1 |
| Welch, BG | 1 |
| Israel, R | 1 |
| O'Mara, V | 1 |
| Austin, B | 1 |
| Bellucci, A | 1 |
| Meyer, BR | 1 |
| Webb, D | 1 |
| Buss, DC | 1 |
| Fifield, R | 1 |
| Bateman, DN | 1 |
| Routledge, PA | 1 |
| Lehmann, CR | 1 |
| Heironimus, JD | 1 |
| Collins, CB | 1 |
| O'Neil, TJ | 1 |
| Pierson, WP | 1 |
| Crowe, JT | 1 |
| Melikian, AP | 1 |
| Wright, GJ | 1 |
| Buyan, RD | 1 |
| Schroeder, RL | 1 |
| Perkins, WE | 1 |
3 trials available for metoclopramide and Kidney Diseases
| Article | Year |
|---|---|
Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer.
Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protoc | 2002 |
[A double-blind study of the analgesic efficacy in kidney colic of the combination of dipyrone and spasmolytic with ketorolac trometamol].
Topics: Acute Disease; Adolescent; Adult; Aged; Analgesics; Butylscopolammonium Bromide; Colic; Dipyrone; Do | 1993 |
Effect of metoclopramide on dopamine-induced changes in renal function in healthy controls and in patients with renal disease.
Topics: Adult; Aldosterone; beta 2-Microglobulin; Blood Pressure; Dopamine Antagonists; Dose-Response Relati | 1988 |
8 other studies available for metoclopramide and Kidney Diseases
| Article | Year |
|---|---|
Metoclopramide in patients with renal failure.
Topics: Humans; Kidney Diseases; Metoclopramide | 1983 |
The pharmacokinetics of metoclopramide in rats with experimental renal and hepatic dysfunction.
Topics: Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Kidney Diseases; Ki | 1981 |
The disposition and protein binding of batanopride and its metabolites in subjects with renal impairment.
Topics: Adult; Aged; Blood Proteins; Female; Humans; Kidney Diseases; Male; Metoclopramide; Middle Aged; Pro | 1993 |
Studies of renin activation and regulation of aldosterone and 18-hydroxycorticosterone biosynthesis in hyporeninemic hypoaldosteronism.
Topics: 18-Hydroxycorticosterone; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Corticosterone; Enz | 1985 |
Metoclopramide decreases renal plasma flow.
Topics: Aged; Blood Pressure; Cisplatin; Dopamine Antagonists; Drug Evaluation; Female; Humans; Iodohippuric | 1986 |
The plasma protein binding of metoclopramide in health and renal disease.
Topics: Blood Proteins; Humans; In Vitro Techniques; Kidney Diseases; Kidney Failure, Chronic; Metoclopramid | 1986 |
Metoclopramide kinetics in patients with impaired renal function and clearance by hemodialysis.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Chromatography, Gas; Creatinine; Female; Half-Life; H | 1985 |
Lack of effect of metoclopramide on cisplatin-induced nephrotoxicity in rats.
Topics: Animals; Body Weight; Cisplatin; Female; Kidney; Kidney Diseases; Metoclopramide; Rats; Rats, Inbred | 1985 |